ArticleInvestigational new drugs2020

A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors.

Mojun Zhu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.